HIV, human immunodeficiency virus HIV-l, human immunodeficiency virus-type 1 PE, phycoerythrin PCR, polymerase chain reaction rhGM-CSF, recombinant human granulocyte-macrophage colony-stimulating factor FL, fluorescence AIDS is the result of infection of susceptible cells by HIV-1 (1, 2) . Although the tropism of HIV-l for CD4+ lymphocytes and monocytes appears to be central in the pathogenesis of disease (3) , abnormalities in hematopoiesis with resultant. peripheral blood cytopenias also occur (4, 5) . Granulocytopema has been reported in most patients with AIDS or AIDS-related complex (6) . An even higher incidence of anemia has been noted III a series of individuals with AIDS (7) . Similar abnormalities are observed in HIV-infected infants and in others who show only transient HIV seropositivity due to transplacentally acquired anti-HIV antibody (8) .
The bone marrow and hematopoietic progenitor cell compartments are defective in HIV-l patients (9, 10) . Dysregulation of hematopoiesis by alteration in the T cell subpopulations (11) , production of inhibiting glycoproteins (12) , antibody-mediated cytotoxicity (13) , and infection of hematopoietic progenitor cells by HIV-l (14) have all been implicated as pathogenetic mechanisms. Bone marrow specimens taken from patients with AIDS exhibit myelodysplastic changes (15) . A reduced proliferative capacity in vitro of CFU-GM from the bone marrow of 16 out of 18 patients with AIDS and concurrent neutropenia has been described. Significant reduction of CFU-GEMM, BFU-E, and CFU-MK has also been observed (11) .
Matemofetal transmission of HIV-1 resulting in children with AIDS is emerging as a major manifestation of this disease. There is a high risk (about 30%) of HIV-l infection in children born to seropositive mothers (16, 17) . Because the majority of children with AIDS are congenitally infected by HIV-l, hematopoietic organs other than the bone marrow may have a direct relationship with the hematologic abnormalities associated with pediatric AIDS. Because the liver represents the major organ of extramedullary hematopoiesis during fetal life and HIV-infected children are believed to be infected in utero (18) , some of the hematologic manifestations related to pediatric AIDS may be the product of infection of hematopoietic stem cells in the human fetal liver. To investigate these possibilities, fetal liver hematopoiesis in abortuses of women infected by HIV was studied in vitro and compared to that in normal control fetuses. Maternal and fetal blood studies. Five HIV-seropositive and eight normal control 2nd trimester pregnant women were studied. Routine blood studies included complete blood count [using the Coulter S plus IV (Hialeah, FL)], total lymphocyte count, T4 and T8 subsets, and coagulation profile. Sera from all patients were tested for antibodies to HIV using the ELISA and Western blot techniques. Fetal cord blood and amniotic fluid were analyzed for anti-HIV antibodies by ELISA and Western blot techniques.
Analysis of HIV-l infection offetal tissues. The potential of HIV-l infection of fetal liver and other tissues was determined by autoradiography after PCR of potential HIV-l DNA sequences.
Abortuses were obtained after dilation and extraction. Within 10 min of fetal demise, the external surface of the abortus was thoroughly rinsed with saline and the fetus surgically dissected to yield tissue samples including, but not restricted to, CNS, liver, and lung. The tissues were snap frozen in liquid nitrogen and maintained at -70°C until analyzed. For DNA analysis, tissues were thawed on ice and mechanically dissociated into cell suspensions by passage through a sterile stainless steel mesh screen, cells were washed by sedimentation through PBS, and nucleic acids were deproteinized by standard phenol, chloroformisoamyl alcohol purification.
One tJ.g of tissue DNA was amplified for 30 cycles using the "gag" oligonucleotide primers SK38 and 39, the thermostable "tac" polymerase, and the salt and Mg optimization as described by the manufacturer (Cetus, San Francisco, CA). Detection of HIV-l DNA was accomplished using the radiolabeled SKl9 probe. In each case, a negative control DNA was obtained from a blood donor who was without risk factors for HIV-1 infection and who had been determined to be seronegative. Positive control DNA was composed of 1 .tJ.g of HIV-l-negative DNA to which had been added measured quantities of HIV-1 plasmid DNA genome copies or measured quantities of whole cell DNA from the 8E5-LAV cell. This cell line is known to contain a single proviral copy of HIV-1. All amplifications included both negative and positive controls and were done at least in duplicate.
Tissue culture. Fetal livers were obtained within 10 min of delivery. The organs were placed in Hanks' balanced salt solution containing 0.1% heparin. The livers were dissected sterilely and cells collected into 50-mL centrifuge tubes, and tissue debris and aggregates were allowed to settle by gravity. A mononuclear cell preparation was prepared by centrifugation over Ficoll Hypaque. The cells at the interface were washed twice in Hanks' balanced salt solution and the number of viable cells determined using trypan blue.
Cell cultures. In each experiment, HIV-positive and control cells were simultaneously cultured using the same conditions. RPMI-1640 (GIBCO Laboratories, St. Lawrence, MA) supplemented with 10% FCS (GIBCO), 100 units of penicillin, 5 mg streptomycin, and 0.9% methyl cellulose was used (wt/vol), Part of each sample was cultured in liquid suspension without addition of methylcellulose. The cells were resuspended in the medium and adjusted to 5 X 10 5 cells/ml., One mL of cell suspension was cultured in either 24-well or 6-well tissue culture plates. Cells were cultured in the presence of 1 IV/ml. Ep (purified human urine ICN Biochemicals, Cleveland, OH) and rhGM-CSF (Genzyme, Boston, MA) at 5 IU/mL. In some wells, only Ep or GM-CSF was added to the cell suspension.
After 5, 10, and 21 d of incubation at 3rC and 5% CO2 in a moist atmosphere, cell colonies were examined, classified, and Statistical analysis. The results were analyzed using the "Statistics" program (version 5.1), produced by Basic Business Software, Inc. (New York, NY). The colony counts were analyzed by the t test and the flow cytometric data by the t test after conversion by two-way analysis of variance.
RESULTS

Maternal blood studies.
Maternal blood studies including Hb, total white cell count, total lymphocytes, T4:T8 ratio, platelet count, and mean platelet volume are shown in Table 2 . Of the five HIV-seropositive females, one woman suffered from a microcytic hypochromic anemia and another had leukopenia. All women had abnormal T4:T8 ratios. Two women presented with thrombocytopenia; both showed an increase in mean platelet volume that probably is due to an immune process. There were no abnormal values in the blood samples for the control females.
PotentialHIV-I infection offetal tissue. There was no evidence
by PCR to support the conclusion that any of the fetal tissues examined as part of this study were infected by HIV. Table 3 The major difference noted in this study was in the early T and B lineages, which showed a significant decrease in the percentages of cells originating from the liver of fetuses of HIVseropositive women. One can speculate that the deficiency of immature lymphoid elements could be related to a maternal suppressor factor or factors secreted by T cell subpopulations. This may be the same mechanism that is responsible for lymphopenia observed in peripheral blood of patients with AIDS.
Fetalliverhematopoietic cultures.
Leiderman et al. (19) were the first to describe a reduced in vitro proliferative capacity of CFU-GM from the bone marrow of 16 out of 18 patients with AIDS and concurrent neutropenia. It was concluded that bone marrow cells from patients with AIDS released a factor inhibitory for normal granulopoietic progenitor cells. It was further reported (20) that bone marrow progenitors isolated from AIDS patients are responsive to rhGM-CSF and recombinant Ep and that antibodies present in the serum of patients infected with HIV could suppress the growth of these progenitors. A component of this immune-mediated suppression appears to be antibodies directed toward the envelope glycoprotein (gp 120) ofHIV-1.
A decrease in CFU-GEMM, CFU-MK, BFU-E, and CFU-GM from bone marrow of patients with AIDS was found to be inversely correlated with the number of circulating CD4 cells and the T4:T8 ratio (21) . This observation leads to the conclusion that an imbalance of T cell subpopulations appears to be mainly responsible for the progressive impairment of proliferation and differentiation of bone marrow progenitor cells observed in HIVinfected individuals. The present report demonstrates a decrease in myelomonocytes (CD33), panleukocytes (CD45), and early monocytes (CDI4), but we failed to demonstrate any suppression of BFU-E, CFU-GM, CFU-GEMM, and CFU-MK. There was some evidence that those hematopoietic cells are more responsive PCR that demonstrated the presence of 10-25 HIV-l genome copies of control positive samples, no positive signal was detected. Therefore, other mechanisms are suspected to be responsible for the observed results.
These findings could be due to a rebound phenomenon. Because T cells can inhibit the proliferation and differentiation of normal hematopoietic progenitor cells (by cell to cell interaction as well as by production of inhibitor factor), the separation of these progenitor cells from the endogenous inhibiting effect and the exposure to stimulating growth factor could produce the rebound effect.
The increase in CDI4 phenotype in hematopoietic fetal liver cultures of abortuses from HIV-seropositive mothers could be similarly explained because most of the patients with AIDS have diminished numbers ofcirculating monocytes (6) . All liver tissues were analyzed by PCR for HIV-I DNA sequences and found to be negative. This fact supports our hypothesis that changes observed in the in vitro hematopoiesis of abortuses of HIVseropositive women might be a rebound effect caused by inhibitors produced by the maternal T cell subpopulations or a lack of inhibitors due to a significantly diminished number of early T cells observed in liver tissue of those abortuses. Infection of a small subpopulation of hematopoietic progenitor cells or macrophages could not be excluded in our study, but it is unlikely because infected progenitor cells lose their capacity to proliferate (11 ) .
In conclusion, the present data demonstrate that fetuses of HIV-seropositive women exhibit a normal or even increased ability of their hematopoietic cells to proliferate and differentiate in tissue culture regardless of a direct or indirect HIV effect on the hematopoietic system of the host. Infection of a small subpopulation of hematopoietic progenitor cells below the level of detectability of the PCR, however, cannot be excluded. Whatever the mechanism causing bone marrow alterations in patients with AIDS, it appears not to have a nonreversible impact on the potential of fetal hematopoietic cells to differentiate. Table 5 . Flow cytometric analysis ofcells after 10 d in cultures* CD45 CDI4 Transferrin CD36 CD61 CD33 NCEp+ 13 ± 2 6±1 84 ± 6 73 ± 7 6 ± I 14 ± 3 GM-CSF HIV fetus Ep II ± 2 II ± 3 71 ± 9 68 ± 4 8 ± I 26 ± 4 + GM-CSF NC GM-CSF 34 ± 7 20 ± 3 29 ± 6 34 ± 7 24 ± 6 45 ± 9 HIV fetus 27 ± 10 27 ± 6 29 ± 3 35 ± 4 II ± 3 55 ± 10 GM-CSF NCEp+ 38 ± II 9 ± 2t 51 ± 9 49 ± 10 14 ± I 4 ± It GM-CSF HIV fetus Ep 30 ± 5 22 ± 4t 68 ± 13 62 ± 6 17 ± 7 14 ± 3t + GM-CSF NCGM-CSF 37 ± 16 29 ± 6 9±3 21 ± 8 20 ± 4 25 ± 6 HIV fetus 40 ± 7 39 ± 7 16 ± 3 26 ± 4 16 ± 8 16 ± 4 GM-CSF to stimulation with Ep+GM-CSF or GM-CSF alone. There was an increased number ofBFU-E on d 5 and 10 in HIV-associated cultures when compared to normal controls. Furthermore, phenotype analysis of cultured hematopoietic cells showed a significant increase in the number of CDl4-positive cells on d 10, as well as a significant increase in the number of CD45-positive cells on d 21 .
Although there remains a possibility that the observed changes are the product of HIV-I infection of hematopoietic precursor cells, the data obtained by PCR amplification of HIV-I DNA sequences were negative for all liver tissues. Under conditions of
